ARCHIVES

Adverse data from cancer prevention trial makes Merck withdraw Vioxx from market. Researchers discuss implications for other cancer prevention trials.

This article is from The Cancer Letter archive.

Vol. 30 No. 39 | October 15, 2004

Download PDF Visit The Full Archive

Related Articles

DCPC Concepts OKd Include Nurse Research Training

May 25, 1984

New Policy on Minor Changes in Trials Requires Halt in Patient Enrollment.

April 25, 2008

Maxine Singer Wins Top SES Award

January 8, 1988

Three Experimental Beamlines To Be Built For Research.

May 17, 2002

NCI CTEP Approved Trials For the Month of April

April 26, 2013

NIH Negotiating On Straus Grant; Committee Asks for One Probe

July 17, 1981